Obesity as a model of premature immunosenescence

Current Immunology Reviews

Volumn 8, Issue 1, 2012, Pages 63-75

  de la Fuente, Mónica ^a   de Castro, Nuria M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Immune function; Immunosenescence; Obesity; Oxi inflamm aging; Premature aging

Indexed keywords

ADIPONECTIN; GHRELIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; AGE; AGED; AGING; ANIMAL MODEL; ARTICLE; DISEASE MODEL; GENETIC MODEL; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IN VIVO STUDY; INFLAMMATION; LONGEVITY; NONHUMAN; OBESITY; OXIDATIVE STRESS; PREMATURE IMMUNOSENESCENCE; PRIORITY JOURNAL; STRESS;

EID: 84856456222     PISSN: 15733955     EISSN: 1875631X     Source Type: Journal    
DOI: 10.2174/157339512798991290     Document Type: Article

References (106)

1. De la Fuente M, Miquel J. An update of the oxidationinflammation theory of aging:the involvement of the immune system in oxi-inflamm-aging. Curr Pharm Des 2009; 15: 3003-26.
2. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 2: 298-300.
3. Harman D. The biological clock. The mitochondria? J Am Geriatr Soc 1972; 20: 99-117.
4. Miquel J, Economos AC, Fleming J, Johnson JEJr. Mitochondrial role in cell aging. Exp Gerontol 1980; 15: 575-91.
5. Barja G. Free radicals and aging. Trends Neurosci 2004; 27: 595-600.
6. Miquel J. An update on the oxygen stress-mitochondrial mutation theory of aging: genetic and evolutionary implications. Exp Gerontol 1998; 33: 113-26.
7. Sies H. Biochemistry of oxidative stress. Angewandte Chem 1986; 25: 1058-71.
8. Knight JA. Review: Free Radicals, Antioxidants, and Immune System. Ann Clin Lab Sci 2000; 30: 145-58.
9. Yoon SO, Yun ChH, Cheng AS. Dose effect of oxidative stress on signal transduction in aging. Mech Ageing Develop 2002; 50: 1-8.
10. Williams GC. Pleiotropy, natural selection and the evolution of senescence. Evolution 1957; 2: 397-411.
11. Weissman A. Essays upon heredity and kindred biological problems. London-New York: Oxford University Press-Clarendon; 1891.
12. Borkan A, Norris AH. Asessment of biological age using a profile of physical parameters. J Gerontol 1980; 35: 177-84.
13. Benfante R, Reed D, Brody J. Biological and social predictors of health in an aging cohort. J Chronic Dis 1985; 38: 385-95.
14. Bae CY, Kang YG, Kim S, et al. Development of models for predicting biological age (BA) with physical, biochemical, and hormonal parameters. Arch Gerontol Geriatr 2008; 47: 253-65.
15. Bulpitt CJ, Antikainen RL, Markowe HL, Shipley MJ. Mortality according to a prior assessment of biological age. Curr Aging Sci 2009; 2: 193-9.
16. Ogata K, Yokose N, Tamura H, et al. Natural killer cells in the later decades of human life. Clin Immunol Immunopathol 1997; 84: 269-75.
17. Guayerbas N, Puerto M, Victor VM, Miquel J, De la Fuente M. Leukocyte function and life span in a murine model of premature immunosenescence. Exp Gerontol 2002; 37: 249-56.
18. Guayerbas N, Catalan M, Victor VM, Miquel J, De la Fuente M. Relation of behaviour and macrophage function to life span in a murine model of premature immunosenescence. Behav Brain Res 2002; 134: 41-8.
19. Guayerbas N, De La Fuente M. An impairment of phagocytic function is linked to a shorter life span in two strains of prematurely aging mice. Dev Comp Immunol 2003; 27: 339-50.
20. De la Fuente M, Hernanz A, Vallejo, MC. The immune system in the oxidation stress conditions of aging and hypertension. Favorable effects of antioxidants and physical exercise. Antioxid Redox Signal 2005; 7: 1356-66.
21. Wayne SJ, Rhyne RL, Garry PJ, Goodwin JS. Cell-mediated immunity as a predictor of morbidity and mortality in subjects over 60. J Gerontol 1990;45: M45-8.
22. Ma YX, Yue Z, Wang ZS, et al. Physiological basis for long life span. Mech Ageing Dev 1997; 98: 47-55.
23. Pawelec G, Barnett Y, Forsey R. T cells and aging. Front Biosci 2002; 7: d1056-d83.
24. Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology 2007; 120: 435-46.
25. High KP. Infection as a cause of age-related morbidity and mortality. Ageing Res Rev 2004; 3: 1-14.
26. Grubeck-Loebenstein B, Della Bella S, Iorio AM, Michel JP, Pawelec G, Solana R. Immunosenescence and vaccine failure in the elderly. Aging Clin Exp Res 2009; 21: 201-9.
27. Franceschi C, Monti D, Barbieri D, et al. Immunosenescence in humans: deterioration or remodelling? Int Rev Immunol 1995; 12: 57-74.
28. Gomez CR, Nomellini V, Frunce DE, Kovacs EJ. Innate immunity and aging. Exp Gerontol 2008; 43: 718-28.
29. Szabo P, Li F, Mathew J, Lillvis J, Weksler ME. Evolution of Bcell clonal expansions with age. Cell Immunol 2004; 231: 158-67.
30. Trzonkowski P, Szmit E, Mysliwska J, Mysliwski A. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impacto of immunosenescence. Clin Immunol 2006; 119: 307-16.
31. De la Fuente M, Hernanz A, Guayerbas N, Álvarez P, Alvarado C. Changes with age in peritoneal macrophage functions. Implication of leukocytes in the oxidative stress of senescence. Cell Mol Biol 2004, 50: 683-90.
32. Sebastian C, Espia M, Serra M, Celada A, Lloberas J. MacrophAging: a cellular and molecular review. Immunobiol 2005; 210: 121-6.
33. De la Fuente M. Role of neuroimmunomodulation in aging. Neuroimmunomodulation 2008; 15: 213-23.
34. Solana R, Pawelec G, Tarazona R. Aging and innate immunity. Immunity 2006; 24: 491-4.
35. De la Fuente M, Hernanz A, Guayerbas N, Victor VM, Arnalich F. Vitamin E ingestion improves several immune functions in elderly men and women. Free Radic Res 2008; 42: 272-80.
36. De la Fuente M. Changes in the macrophage function with aging. Comp Biochem Physiol 1985; 81: 935-8.
37. Rafi A, Castle SC, Uyemura K, Makinodan T. Immune disfunction in the elderly and its reversal by antihistaminas. Biomed Pharmacother 2003; 57: 246-50.
38. Alberti S, Cevenini E, Ostan R, et al. Age-dependent modifications of type 1 and type 2 cytokines within virgen and memory CD4+ T cells in humans. Mech Ageing Dev 2006; 127: 560-6.
39. Colonna-Romano G, Bulati M, Aquino A, et al. A double-negative (IgD-CD27-) B cell population is increased in the peripheral blood of elderly people. Mech Ageing Dev 2009; 130: 681-90.
40. Wrona D. Neural-immune interactions: An integrative view of bidirectional relationship between the brain and immune systems. J Neuroimmunol 2006; 172: 38-58.
41. Besedovsky HO, Del Rey A. Physiology of psychoneuroimmunology: a personal view. Brain Behav Immun 2007; 21: 34-44.
42. Fabris N. A neuroendocrine-immune theory of aging. Int J Neurosci 1990; 51: 373-5.
43. Kulinsky VI. Biochemical aspects of inflammation. Biochemistry 2007; 72: 595-607.
44. Csiszar A, Wang M, Lakatia EG, Ungvari Z. Inflammation and endothelial dysfunction during aging: role of NF-kappaB. J Appl Physiol 2008; 105: 1333-41.
45. Salvioli S, Capri M, Valensin S, et al. Inlamm-aging, cytokines and aging: state of the art, new hypotheses on the role of mitochondria and new perspectivas from systems biology. Curr Pharm Design 2006; 12: 3161-71.
46. Candore G, Caruso C, Jirillo E, Magrote T, Vasto S. Low grade inflammation as a common pathogenetic denominador in agerelated diseases: novel drug targets for anti-ageing strategies and successful ageing achievement. Current Pharm Des 2010, 16: 584-596.
47. Ostan R, Bucci L, Capri M, et al. Immunosenescence and immunogenetic of human longevity. Neuroimmunomodulation 2008; 15: 224-43.
48. Viveros MP, Arranz L, Hernanz A, Miquel J, De la Fuente M. A model of premature ageing in mice based on altered stress-related behavioural response and immunosenescence. Neuroimmunomodulation 2007; 14: 157-62.
49. Alonso-Fernandez P, Puerto M, Maté I, Ribera JM, De la Fuente M. Neutrophils of centenarians show function levels similar to those of adults. J Am Geriatr Soc 2008; 56: 2244-51.
50. Alonso-Fernandez P, De la Fuente M. Role of the immune system in aging and longevity. Curr Aging Sci 2011; 4(2): 78-100.
51. Puerto M, Guayerbas N, Alvarez, P, De la Fuente M. Modulation of neuropeptide Y and norepinephrine on several leucocyte functions in adult, old and very old mice. J Neuroimmunol 2005; 165: 33-40.
52. Arranz L, Caamano J, Lord JM, De la Fuente M. Preserved immune functions and controlled leukocyte oxidative stress in long-lived mice: Possible role of nuclear factor-kappaB. J Gerontol A Biol Sci Med Sci 2010; 65(9): 941-50.
53. De la Fuente M, Gimenez-Llort L. Models of Aging of Neuroimmunomodulation. Strategies for its Improvement. Neuroimmunomodulation. 2010; 17: 213-6.
54. Arranz L, De Castro NM, Baeza I, Maté I, Viveros MP, De la Fuente M. Environmental enrichment improves age-related immune system impairment. Long exposure since adulthood increases life span in mice. Rejuvenation Res 2010; 13(4): 415-28.
55. De la Fuente M, Baeza I, Guayerbas N,. et al. Changes with aging in several leukocyte functions of male and female rats. Biogerontol 2004; 5: 389-400.
56. Baeza I, De Castro NM, Gimenez-Llort L, De la Fuente M. Ovariectomy, a model of menopause in rodents, causes a premature aging of the nervous and immune systems. J Neuroimmunol 2010; 219: 90-9.
57. De Ferranti S, Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008; 54: 945-55.
58. Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4-12.
59. Hjartåker A, Langseth H, Weiderpass E. Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol 2008; 630: 72-93.
60. Marinou K, Tousoulis D, Antonopoulos AS, Stefanadi E, Estefanadis C. Obesity and cardiovascular disease: from pathophysiology to risk stratification. Int J Cardiol 2010; 138: 3-8.
61. Trayhurn P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005; 33: 1078-81.
62. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6: 772-83.
63. Gil A, María Aguilera C, Gil-Campos M, Cañete R. Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity. Br J Nutr 2007; 98: S121-6.
64. Ferrante AW Jr. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J Intern Med 2007; 262: 408-14.
65. Cancello R, Clément K. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 2006; 113: 1141-7.
66. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-9.
67. Mussad S, Haynes EN. Biomarkers of obesity and subsequent cardiovascular events. Epidemiol Rev 2007; 29: 98-114.
68. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15: 2792-800.
69. Picchi A, Gao X, Belmadani S, et al. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 2006; 99: 69-77.
70. Guzik TJ, Mangalat D, Korbut R. Adipocytokines-novel link between inflammation and vascular function? J Physiol Pharmacol 2006; 57: 505-28.
71. Ahima RS, Flier JS. Leptin. Annu Rev Physiol 2000; 62: 413-37.
72. Matarese G. Leptin and the immune system: how nutritional status influences the immune response. Eur Cytokine Netw 2000; 11: 7-14.
73. Ouchi N, Kihara S, Arita Y, et al. Adiponectin, an adipocytederived plasma protein, inhibits endothelial KF-kappaB signalling through a camp-dependent pathway. Circulation 2000; 102: 1296-301.
74. Taub DD. Novel connections between the neuroendocrine and immune systems: the ghrelin immunoregulatory network. Vitam Horm 2008; 77: 325-46.
75. Martín-Romero C, Santos-Alvarez J, Goberna R, Sánchez-Margalet V. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol 2000; 199: 15-24.
76. Sánchez-Margalet V, Martín-Romero C, Santos-Alvarez J, Goberna R, Najib S, González-Yanes C. Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin Exp Immunol 2003; 133: 11-9.
77. Matarese G, Moschos S, Mantzoros CS. Leptin in immunology. J Immunol 2005; 174: 3137-42.
78. Stofkova A. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul 2009; 43: 157-68.
79. Bernotiene E, Palmer G, Gabay C. The role of leptin in innate and adaptive immune responses. Arthritis Res Ther 2006; 8: 217.
80. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000; 68: 437-46.
81. Granado M, Priego T, Martin AI, Villanua MA, Lopez-Calderon A. Antiinflammatory effect of the ghrelin agonist growth hormonereleasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab 2005; 288: E486-492.
82. Gonzalez-Rey E, Chorny A, Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 2006; 130: 1707-20.
83. Wiedmer P, Nogueiras R, Broglio F, D'Alessio D, Tschop MH. Ghrelin, obesity and diabetes. Nat Clin Pract Endocrinol Metab 2007; 3: 705-12.
84. Shimokawa I, Higami Y. Leptin signaling and aging: insight from caloric restriction. Mech Ageing Dev 2001: 122: 1511-9.
85. Dixit VD, Taub DD. Ghrelin and immunity: a young player in an old field. Exp Gerontol 2005; 40: 900-10.
86. Dixit VD, Schaffer EM, Pyle RS, et al. Ghrelin inhibits leptin-and activation-induced pro-inflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004; 114: 57-66.
87. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007; 8: 21-34.
88. Di Francesco V, Zamboni M, Zoico E, et al. Unbalanced serum leptin and ghrelin dynamics prolong postprandial satiety and inhibit hunger in healthy elderly: another reason for the "anorexia of aging". Am J Clin Nutr 2006; 83: 1149-52.
89. Amati L, Cirimele D, Pugliese V, Covelli V, Resta F, Jirillo E. Nutrition and immunity: laboratory and clinical aspects. Curr Pharm Des 2003; 9: 1924-31.
90. Ongrádi J, Stercz B, Kövesdi V, Vértes L. Immunosenescence and vaccination of the elderly II. New strategies to restore age-related immune impairment. Acta Microbiol Immunol Hung 2009; 56: 301-12.
91. Chen J, Li J, Lim FC, et al. Maintenance of naivë CD8 T cells in nonagenarians by leptin, IGFBP3 and T3. Mech Ageing Dev 2010; 131: 29-37.
92. Dixit VD, Yang H, Sun Y, et al. Ghrelin promotes thymopoiesis during aging. J Clin Invest 2007; 117: 2778-90.
93. Carroll L, Voisey J, Van Daal A. Mouse models of obesity. Clin Dermatol 2004; 22: 345-9.
94. Imai Y, Ahima RS. Rodents as genetic models of obesity. Drug Discov Today Dis Models 2005; 2: 165-75.
95. Lindström P. The physiology of obese-hyperglycemic mice [ob/ob mice]. ScientificWorldJournal 2007; 7: 666-85.
96. Shore SA. Obesity and asthma: lessons from animal models. J Appl Physiol 2007; 102: 516-28.
97. Sharma K, McCue P, Dunn SR. Diabetic kidney disease in the db/db mouse. Am J Physiol Renal Physiol 2003; 284: F1138-44.
98. Palmer G, Aurrand-Lions M, Contassot E, et al. Indirect effects of leptin receptor deficiency on lymphocyte populations and immune response in db/db mice. J Immunol 2006; 177: 2899-907.
99. Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J Med Res 2007; 125: 451-72.
100. Bray GA. The Zucker-fatty rat: a review. Fed Proc 1977; 36: 148-53.
101. White BD, Martin RJ. Evidence for a central mechanism of obesity in the Zucker rat: role of neuropeptide Y and leptin. Proc Soc Exp Biol Med 1997; 214: 222-32.
102. Aleixandre de Artiñano A, Miguel Castro M. Experimental rat models to study the metabolic syndrome. Br J Nutr 2009; 102: 1246-53.
103. Kleyn PW, Fan W, Kovats SG, et al. Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell 1996; 85: 281-90.
104. Matarese G, La Cava A. Immune responses in obesity models. Drug Discov Today Dis Models 2005, 2: 177-181.
105. Ikemoto S, Takahashi M, Tsunoda N, Maruyama K, Itakura H, Ezaki O. High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils. Metabolism 1996; 45: 1539-46.
106. Van Heek M, Compton DS, France CF, et al. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 1997; 99: 385-90.